Award
Delivery Order #SPE2DR26FSMH7
Pharmaceutical Tablet Delivery under DMS Pharmaceutical Group IDV Contract
Buyer
Defense Logistics Agency
Award Amount
$3,225.60
Ceiling
$3,225.60
Awarded
February 20, 2026
Period of Performance
Feb 20, 2026 – Feb 23, 2026
Identifier
SPE2DR26FSMH7
NAICS
424210
This contract represents a delivery order awarded to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical product distribution, under an existing indefinite delivery vehicle (IDV) contract aimed at supplying various essential medications. Specifically, the order involves the procurement of IOSAT 130 mg tablets, highlighting the company's role in ensuring the availability of critical pharmaceutical products. The recipient's business focus aligns with supporting public health initiatives by maintaining a steady and reliable supply chain. The contract is significant for the agency as it contributes to uninterrupted access to necessary medications, thereby supporting ongoing healthcare services and public welfare. The scope of work covers the delivery of this specific pharmaceutical product to the designated location in Park Ridge, Illinois, over a concise performance period of a few days in 2026. This delivery order is part of a larger, competitively awarded IDV contract that exemplifies prudent government acquisition practices targeting best value solutions. The contract timeline spans from the award date in early 2026 through the short delivery window. This award builds upon the parent IDV contract initially awarded through competitive bidding, ensuring consistency and reliability in pharmaceutical supplies over multi-year performance.
Description
4571032443!IOSAT 130 MG TABLET 14S